Epidural Steroid Injections - (Effective Date - 2026-10-15) 7.01.115
Summary
Excellus BlueCross BlueShield medical policy 7.01.115 on epidural steroid injections (ESIs) and selective nerve root blocks (SNRBs) has a current effective date of October 15, 2026. Initial ESIs are considered medically appropriate for presumed radiculopathy or radicular pain after at least four weeks of conservative treatment, participation in a comprehensive pain management program, and level-specific neurologic findings, with advanced imaging within the past 24 months required for cervical/thoracic interlaminar and transforaminal ESIs. Repeat ESIs require at least 14 days since the prior injection and documented pain relief of at least 50% for at least two weeks, and ESIs are limited to three sessions per episode of pain per region in six months and four sessions per region in a rolling 12 months. ESIs performed with ultrasound guidance or with injectates other than anesthetic, corticosteroid, and/or contrast agent are considered investigational.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.